Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RGEN · against 162 other Healthcare companies of similar size
Ranked #22 of 163 · scores higher than 87% of peers · safety percentile 81
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)11 peers with a safety percentile of 80–89, including RGEN · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 158 reported | 0.33× | 0.34× | 52% | 33% | |
| BetaLower is better · 164 reported | 1.05 | 0.58 | 23% | 33% | |
| Current ratioHigher is better · 155 reported | 9.05× | 2.29× | 90% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 5.7B USD | 97 | 52 | |
| 18 | 5.1B USD | 85 | 35 | |
| 19 | 20.0B AUD (≈$13.2B) | 84 | 77 | |
| 20 | 6.0B USD | 84 | ||
| 21 | 49.0B CNY (≈$6.9B) | 82 | 60 | |
| 22 | 10.1B USD | 81 | 61 | |
| 23 | 1.13T INR (≈$13.5B) | 80 | 61 | |
| 24 | 7.3B USD | 80 | 74 | |
| 25 | 679.6B INR (≈$8.2B) | 78 | 77 | |
| 26 | 6.2B USD | 78 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score